Oklo Inc. ($OKLO): Aurora, Nuclear Fuel, Isotopes and the Road to First Power

01 The investment thesis in one page

Firm power for an AI-constrained grid

Data centers, defense sites and industrial customers need continuous electricity, not only annual renewable-energy matching. Oklo is positioning compact reactors close to load, with long-term power contracts and a company-owned fleet.

Execution before economics

There is no operating Aurora plant, no commercial power revenue and no accepted new full NRC combined-license application disclosed at the cut-off. The central question is not addressable demand; it is whether Oklo can license, fuel, finance, construct and operate on schedule.

Optionality already has a price

At the August 6 close of $42.19 and 186.0 million shares, the equity was worth about $7.85 billion. Against $3.01 billion of cash and marketable securities at June 30, the rough enterprise value was about $4.84 billion, on quarterly revenue of $1.2 million that comes from acquired engineering work rather than from the business model itself.

The cleanest bull case: early DOE projects demonstrate real operating capability; the Idaho Aurora reaches power; fuel routes become dependable; customer frameworks convert into bankable PPAs; and the build-own-operate model turns one licensed design into a recurring fleet.

The cleanest bear case: authorization, fuel or construction slips make 2028 unrealistic; non-binding customer interest fails to become financed projects; first-of-a-kind costs consume more capital; and additional ATM issuance transfers part of the future upside from existing shareholders to new capital.

02 Company and stock snapshot

Oklo was founded in 2013 by nuclear engineers Jacob DeWitte and Caroline DeWitte and listed on the NYSE in May 2024 after combining with AltC Acquisition Corp. Its strategic difference is ownership: Oklo generally intends to design, build, own and operate powerhouses, then sell electricity and heat under long-duration agreements. That offers potentially recurring revenue and fleet economics, but it also leaves Oklo holding more development, construction, operating and financing risk than a reactor vendor that sells equipment or licenses technology.

The product roadmap starts with the Aurora powerhouse, a compact sodium-cooled fast reactor. The stated product range is approximately 15–75 MWe, with potential larger configurations. Oklo also owns Atomic Alchemy, is developing fuel fabrication and recycling capabilities, and has begun bringing specialized sodium-system work in-house through its June 2026 acquisition of Creative Engineers.

03 Aurora: what the reactor is—and what remains unproven commercially

Aurora is a fast-spectrum reactor that uses liquid sodium as coolant and metallic fuel. Unlike conventional light-water reactors, the primary system can operate at low pressure because sodium boils at a far higher temperature than water. Heat from the reactor is transferred into a conventional steam cycle, where a turbine and generator make electricity.

The EBR-II inheritance

Oklo is not inventing sodium fast reactors from a blank sheet. Its technical lineage draws heavily on the U.S. Department of Energy’s Experimental Breeder Reactor-II at Idaho, which produced roughly 20 MWe, supplied electricity to the site and accumulated about three decades of operating history. EBR-II and the Integral Fast Reactor program demonstrated important passive-safety behavior and fuel-recycling concepts.

That heritage lowers physics risk, but it does not erase commercial execution risk. Aurora still needs a current design basis, modern supply chain, site-specific authorization, completed fuel, construction, commissioning, qualified operators and proof that actual lifetime cost is competitive.

Siemens Energy signed a binding contract in November 2025 to engineer and deliver the first Aurora power-conversion system, including an SST-600 turbine and SGen-100A generator. Kiewit is the lead constructor for the Idaho project. These are meaningful moves from conceptual partnerships toward long-lead procurement, but neither is evidence that the nuclear island is completed.

04 DOE authorization and NRC licensing: two lanes, not one shortcut

Oklo is pursuing projects under two distinct federal regimes. The distinction is essential because a successful DOE pilot does not automatically authorize a commercial fleet across the United States.

Federal sites and pilot reactors

DOE can authorize nuclear activity on DOE sites and is using its Reactor Pilot Program to move selected projects through safety-basis reviews, readiness and startup approval. Aurora-INL, the Groves test reactor and the Pluto test reactor sit within this broader federal pathway.

Investor use: faster evidence of engineering and operating maturity, with direct federal oversight.

Commercial deployment

The Nuclear Regulatory Commission is the core regulator for commercial nuclear facilities. Oklo is engaged in pre-application work on its Aurora combined-license approach and on operator staffing and licensing frameworks.

Investor use: the gating path for repeatable commercial deployment beyond DOE-controlled projects.

History matters: in January 2022 the NRC denied Oklo’s first custom combined-license application without prejudice because essential information was missing. Oklo remained free to reapply. The event was not a permanent rejection of the technology, but it is direct evidence that completeness and review readiness cannot be assumed.

Progress since then is real. In May 2026 the NRC approved Oklo’s Principal Design Criteria topical report for the Aurora powerhouse in Idaho. The approved report can be referenced in future applications and should reduce re-litigation of foundational criteria. It is not, however, a construction permit or operating license.

At the cut-off date, the NRC’s public Oklo page continued to list Aurora under pre-application activities, including audits and reviews. No newly accepted full Aurora combined-license application was identified. A future submission, NRC acceptance for review, requests for additional information, safety evaluation and final authorization are each separate milestones.

Regulatory milestone ladder

05 The fuel stack: awarded material, plutonium option and HALEU supply

Advanced-reactor fuel is both a constraint and a strategic asset. Aurora needs material enriched beyond the conventional reactor range or alternative fissile feedstocks. Russia has historically dominated commercial HALEU availability; U.S. capacity is only beginning to scale. Oklo is trying to build several routes rather than rely on a single supplier.

Aurora Fuel Fabrication Facility

The planned Aurora Fuel Fabrication Facility at Idaho National Laboratory is intended to convert the awarded EBR-II material into the initial core. DOE approved several early safety-design documents in late 2025, and Oklo was selected for DOE’s Fuel Line Pilot Program. Investors should monitor physical construction, equipment installation, safety-basis approval, fuel-production authorization and actual completed fuel—not only document approvals.

Plutonium is a strategic option, not free fuel

DOE has identified nearly 20 metric tons of surplus plutonium that could potentially be made available. Oklo, Exodys, Flibe Energy, SHINE and Standard Nuclear were selected for advanced negotiations. Oklo also announced work with newcleo, whose affiliated investment vehicle could provide up to $2 billion subject to agreements and conditions, and an MOU with Standard Nuclear for potential handling, packaging and third-party offtake pathways.

The upside is material: a domestic fissile bridge could reduce dependence on near-term HALEU enrichment. The caveat is equally material: “selected for negotiations,” “could invest” and “MOU” are not final allocations, funded commitments or regulatory approvals.

Fuel recycling

Oklo argues that used nuclear fuel retains most of its original energy and that fast reactors can use recovered material. Its long-term plan includes an Advanced Fuel Center in Oak Ridge, Tennessee, with a stated development roadmap of up to $1.68 billion and more than 800 jobs. The company has demonstrated key process steps with national laboratories and completed a fast-spectrum plutonium criticality experiment in 2025.

Commercial recycling could eventually create revenue from fuel services, reduce feedstock dependence and improve material utilization. For valuation today it should be treated as long-dated optionality: the facility, licenses, throughput, customer contracts and unit economics do not yet exist at commercial scale.

06 Project map: from test reactors to gigawatt campuses

The timetable spans very different asset classes. Groves has now supplied a fast operating milestone because it is a tiny critical assembly. Aurora-INL remains the first material test of power-plant execution. Ohio is a multi-unit campus whose economics depend on repeatable delivery after the first plant. Investors should not transfer the schedule achieved by a roughly 100-watt test reactor directly to a multi-megawatt commercial powerhouse.

07 Customers and “pipeline”: rank the contract, not the headline megawatts

Oklo has reported roughly 14.1 GW of customer interest. That is commercially valuable, but it is not equivalent to contracted backlog under accounting rules. The majority comes from a 12 GW framework with Switch, and several additional projects are letters of intent. The correct question is how much capacity has a binding PPA, defined price, creditworthy counterparty support, project site, financing structure and regulatory path.

Why Meta is different

The January 2026 Meta agreement is more important than a simple gigawatt headline because it contemplates customer support before power delivery. Meta can prepay for power and fund early development, including fuel activity, while Oklo retains plant ownership. If structured into bankable project contracts, that approach could reduce the equity capital Oklo must supply.

The development site is 206 acres in Pike County, Ohio, on former DOE land. Oklo targets preconstruction and site characterization in 2026, a first phase as early as 2030 and the full 1.2 GW by 2034. Every date remains contingent on site work, licenses, fuel, supply chain, financing and construction.

Pipeline conversion scorecard: named site → funded development → definitive PPA → regulatory application accepted → project financing closed → construction notice to proceed → first power. Megawatts should receive progressively more valuation weight only as they move right across this sequence.

08 Atomic Alchemy and Groves: the nearer operating story

Oklo acquired Atomic Alchemy in February 2025 for a transaction value of approximately $28.4 million, primarily in shares. The subsidiary targets radioisotopes used in medicine, diagnostics, industry and research. Isotope shortages can support high value per unit of output, and the business may create earlier revenue than a commercial Aurora fleet.

What Groves actually is

The Groves project near Lockhart, Texas, is a small zero-power critical assembly with a maximum authorized design power of approximately 100 watts. It is intended to validate reactor physics, fuel handling, startup procedures, operating controls and data for subsequent commercial isotope-production reactors. It will not generate grid electricity, and its scale should not be modeled as a commercial isotope factory.

DOE approved the project’s final documented safety analysis on July 1, 2026 and later granted startup authorization, clearing fuel loading and startup testing. On August 5 Groves achieved first criticality, announced by Oklo the following day through a controlled, self-sustaining nuclear chain reaction at low power. The milestone came less than one year after groundbreaking and closes the immediate startup binary, but it does not establish commercial isotope output, revenue or Aurora-scale power performance.

What the milestone proves—and what it does not

• Operational credibility: Groves is now the first Oklo-controlled reactor to achieve criticality, adding tangible operating evidence after years dominated by design, licensing and development work.
• Procedure validation: data and operating experience can feed later isotope reactor designs and staff qualification.
• Not yet power proof: Groves does not validate the Aurora thermal system, turbine, multi-megawatt heat removal, grid integration or commercial construction cost.
• Not automatic revenue: revenue requires licensed production facilities, isotope separation/purification, quality systems, customers and dependable output.

Atomic Alchemy’s acquired in-process R&D included the Abundantia isotope effort and the longer-dated Meitner/VIPR reactor concept. Management has discussed possible early revenue from purified materials, but commercial volume, margins and timing remain too immature to anchor current valuation.

09 Q2 2026 results: the first revenue line, and a cost base that tripled

Oklo released second-quarter results before the market opened on August 7, 2026 and filed its Form 10-Q the same day. Two things changed against every prior quarter. Revenue is no longer zero, and total operating expenses are running at 2.7 times the level of a year ago.

What the first revenue line is, and is not. Management states in the 10-Q that revenue and cost of sales “primarily resulted from the acquisitions during the six months ended June 30, 2026”. The $1.210 million is engineering and machining work carried in from ARMEC and Creative Engineers, against $0.721 million of cost of sales. It is not power revenue, it is not isotope revenue, and it is not a run rate. The commercial model still depends on selling electricity and heat from an operating powerhouse, and no powerhouse is operating.

The single largest line below the operating loss is interest income. At $23.2 million in the quarter, the yield on the securities portfolio absorbed just under a third of the operating loss. That is a direct consequence of holding roughly $3 billion in cash and short-duration debt securities, and it is one reason the reported net loss looks far smaller than the operating loss. It is also a line that shrinks as the treasury is converted into concrete, steel and fuel.

Where the money went in the first half

The cash flow statement is more informative than the income statement, because it separates the money spent running the company from the money spent building things. In the six months to June 30, operating activities consumed $65.5 million, against $30.7 million a year earlier. Capital expenditure was $126.9 million, of which $32.8 million fell in Q1 and roughly $94.1 million in Q2. Acquisitions absorbed a further $25.7 million net of cash acquired, and other investments $16.5 million.

Adding operating cash use to capital expenditure gives roughly $192.4 million of cash deployed in six months before financing flows, against about $50.7 million in Q1 alone. That is an analytical measure, not company guidance, and it should not be annualised: project spending is lumpy and depends on when long-lead equipment is ordered and paid for. The direction, however, is unambiguous. Property, plant and equipment on the balance sheet rose from $42.3 million at December 31 to $176.2 million at June 30, which is the accounting trace of Groves being built and of early Aurora work.

Long-term debt is $0.7 million. There is effectively no leverage, which removes covenant and refinancing risk but also means every dollar raised so far has been paid for with ownership. Management repeats the standard statement that existing cash, equivalents and marketable securities are expected to fund operations for at least the twelve months following the filing date. That is a going-concern assertion about operations, not a statement that the full Aurora, Ohio, fuel fabrication and recycling programme is financed.

Questions for every earnings update

1. How much capital moved into physical construction versus engineering and corporate expense?
2. What proportion of spending is attached to authorized, contracted projects?
3. Did customer prepayments or government cost-sharing offset project cash needs?
4. How many shares were issued, including ATM sales, employee awards and acquisitions?
5. Did management narrow a milestone to an auditable event, or only restate a target year?
6. Is revenue still acquisition-derived engineering work, or has isotope or power revenue appeared?

10 Capital structure and dilution: the balance sheet was bought with equity

Oklo entered 2026 with an at-the-market equity programme of up to $1.5 billion and completed it during the first quarter, selling approximately 12.38 million shares for about $1,181.9 million of net proceeds, or roughly $95.50 per share net of offering costs. On May 12, 2026 the company filed a new prospectus supplement permitting up to $1.0 billion of additional ATM sales, and in the second quarter it sold a further 10.71 million shares for about $670.0 million net, or roughly $62.55 per share.

The detail worth pausing on: the average net price realised fell from about $95.50 in Q1 to about $62.55 in Q2, a decline of roughly 35%. The company raised capital in both quarters, but the second tranche cost materially more ownership per dollar. Issuance under an ATM is opportunistic by design and tracks the market; it is not a signal about the business. It is, however, a reminder that the cost of this funding model moves with the share price, and that the remaining facility is a live overhang.

Shares outstanding rose from 160.51 million at December 31, 2025 to 185.09 million at June 30, 2026, an increase of about 15.3% in six months, and stood at 186.02 million on the August 4 cover of the 10-Q. Stock-based compensation of $29.9 million was recognised in the half, which is non-cash in the period but economically dilutive over time.

Capital while the market is open

Roughly $3.0 billion of liquidity removes near-term financing pressure entirely, allows long-lead nuclear components to be ordered before project debt exists, and funds construction at Groves and Idaho without waiting for a customer to write a cheque.

More claims on future cash flow

Per-share value depends on the total share count required to reach commercial operation. At the current pace of capital deployment, roughly $192 million of cash out in six months, the treasury covers years rather than decades of a scaling build programme.

The capital test: dilution is productive if each dollar raised de-risks a milestone by more than the ownership percentage surrendered. In the first half of 2026 the money bought a completed test reactor that reached criticality, two engineering businesses and $134 million of net additions to property, plant and equipment. Whether that is a fair exchange for 15% of the company is the judgement each shareholder has to make.

11 Management, ownership and governance

Chief executive and chair Jacob DeWitte and chief operating officer Caroline DeWitte are cofounders, nuclear engineers and spouses. Their technical continuity and long tenure align the company around a coherent product thesis. The combination also concentrates strategic influence and creates a governance factor that deserves explicit monitoring.

Execution capacity is expanding beyond the founders. Kiewit, Siemens Energy, Centrus, national laboratories and acquired sodium specialists provide external and internal capabilities. The real organizational test is whether Oklo can move from a development company into a regulated owner-operator without losing schedule discipline or safety culture.

12 Competitive map: reactor developers, suppliers and substitutes

The broader substitutes are equally important: conventional nuclear uprates and restarts, gas generation with firm fuel supply, renewables plus storage, geothermal and grid transmission. Data-center buyers will choose reliability, time to power and total delivered cost, not reactor novelty alone.

Where Oklo is differentiated

• Build-own-operate model intended to retain recurring power economics.
• Small initial unit size for colocated, defense and constrained-grid loads.
• Fast-reactor fuel flexibility and potential recycling integration.
• Allocated first-core material and an INL site.
• Parallel near-term test-reactor and isotope activities.

Each differentiation also creates a burden: ownership requires capital; small units require repetition; fuel flexibility requires facilities and safeguards; and vertical integration can stretch management across reactor, fuel, isotope and operating businesses simultaneously.

13 Valuation: price the milestones, not imaginary earnings

Oklo has no meaningful revenue, EBITDA or operating cash flow, so P/E and sales multiples are not decision-useful. The $1.210 million booked in Q2 2026 does not change that: it is acquired engineering work, and a sales multiple on it would be meaningless. At the August 6 close of $42.19 on 186.0 million shares, the approximate $7.85 billion market capitalization less $3.01 billion of June 30 liquidity implies a rough enterprise value near $4.84 billion, before adjusting for future burn, restricted uses, leases or subsequent issuance.

That enterprise value represents the market’s present price for intellectual property, regulatory progress, the first Idaho project, customer relationships, fuel-cycle options, isotope assets and the probability-weighted future fleet. It should not be mistaken for a completed-asset valuation.

Milestones compound

Groves operates; DOE authorizes Aurora construction and startup on a credible path; new NRC application is accepted; Centrus and plutonium routes become definitive; Meta funds Ohio; Eielson converts; first power validates cost and availability.

What changes: Oklo begins to deserve a fleet and infrastructure platform valuation rather than a development-company discount.

Progress, with slippage

Documents, procurement and site work advance, but first Aurora moves beyond 2028. Isotope revenue is modest, customer frameworks remain conditional and cash burn rises.

What changes: liquidity supports the company, but discount rates and dilution offset some technical progress.

Time defeats optionality

Fuel or authorization delays widen; construction cost is higher than expected; pipeline conversion stalls; the new ATM is used heavily at lower prices; competitors reach operation first.

What changes: the market values cash and residual technology more heavily than distant fleet economics.

Analyst targets are a sentiment range, not intrinsic value

Published sell-side targets around the cut-off ranged from roughly $14 to $140, with an average near $87 across the available aggregation. Recent opinions included Hold/Neutral ratings as well as bullish targets. The enormous spread is itself the useful information: small changes in probability, timing, cost of capital and long-term fleet size produce radically different present values.

A disciplined model should use milestone probabilities, explicit dilution and project-level capital. Avoid assigning the entire 14.1 GW stated pipeline the same probability or margin. A non-binding 2044 framework and a funded, licensed plant are not equivalent megawatts.

14 Catalyst timeline: what has happened, and what comes next

The Groves reactor is the first end-to-end example of Oklo moving a nuclear project from paper to a running chain reaction, and the dates are all documented. It works as a reference template, because the same authorisation grammar applies to Aurora-INL and to the fuel facilities, on a larger and slower scale.

Six authorisation steps in seven months. The comparison that matters is not against other advanced reactor developers but against the Aurora programme itself, which is a far larger facility on a federal site and carries a different risk profile.

Completed and confirmed

ARMEC, for precision machining and prototyping for the nuclear industry, for $20.5 million of aggregate consideration including a $3.1 million earnout carried at fair value against a $5.0 million maximum. Creative Engineers, for chemical process engineering in sodium and alkali-metal systems, for $12.9 million. Total purchase consideration was $33.4 million, and the purchase accounting is still provisional.

Two of the five steps in the DOE regulatory pathway for the Idaho powerhouse are now cleared, following approval of the Nuclear Safety Design Agreement earlier in 2026.

Non-binding, covering domestically produced HALEU for multiple years of fuel requirements for up to five Aurora powerhouses, with deliveries expected to begin in 2029. Volume, pricing and prepayment terms remain to be negotiated.

A genuine operating milestone. Groves is a low-power test reactor: it does not feed the grid, and it is not yet a commercial isotope production facility.

First revenue of $1.210 million from the acquired engineering businesses, a $48.5 million net loss, $3,006.3 million of cash and securities, and $126.9 million of capital expenditure in the half.

Next catalysts

How to read the status column. Only two entries carry a date that someone other than Oklo controls: the statutory uranium import deadline, and the quarterly reporting cadence. Everything else is a company target or a non-binding framework. That asymmetry is the practical definition of a milestone-driven equity.

15 Complete risk register

16 The quarterly OKLO dashboard

Hard evidence

• Groves first criticality achieved; commercial isotope operation remains future
• Accepted regulatory application
• Binding PPA or final government award
• Fuel physically fabricated and qualified
• Component delivery and verified construction progress
• Project financing or customer cash received
• Revenue and cash margin from isotope products

Soft evidence

• MOU, LOI or “strategic relationship”
• Selected for negotiations
• Capacity “up to” a headline amount
• Target year without intermediate gates
• Laboratory test that does not match plant scale
• Potential investment subject to future conditions
• Pipeline megawatts without project economics

Bottom line: Groves first criticality retires one real execution risk and gives Oklo operating evidence that did not exist at the prior update. It does not validate Aurora’s multi-megawatt power system, commercial construction cost, grid integration or recurring isotope economics. Oklo still has one of the most coherent vertical strategies in advanced nuclear and unusually strong liquidity for a developer with no commercial power revenue, but the per-share outcome depends on converting this test-reactor progress into licensed, fueled and financed commercial assets without overwhelming dilution.

The block below is a snapshot of the Stocktwits flow, with its date. These are opinions of retail traders and non-professional investors, not analyst research, and they measure attention and how one-sided positioning has become rather than anything about the business.

17 Follow the next nuclear catalyst

Milestone updates, market context and new stock hubs from MerlinTrader.

Disclaimer: This research hub is for educational and informational purposes only and is not investment advice, a solicitation or a recommendation to buy or sell any security. Advanced nuclear companies involve regulatory, technical, construction, financing, dilution and market risks. Forward-looking company statements are targets, not guarantees. Verify current filings, regulatory records, prices and personal suitability before making any decision. The author may hold positions in securities discussed.